Magnusson, M. K., Dahlén, R., Strid, H., Isaksson, S., Simrén, M., Lasson, A., . . . Öhman, L. (2013). CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. SAGE Publications.
استشهاد بنمط شيكاغوMagnusson, Maria K., Rahil Dahlén, Hans Strid, Stefan Isaksson, Magnus Simrén, Anders Lasson, Antal Bajor, Kjell-Arne Ung, و Lena Öhman. CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients With Ulcerative Colitis. SAGE Publications, 2013.
MLA استشهادMagnusson, Maria K., et al. CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients With Ulcerative Colitis. SAGE Publications, 2013.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.